BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25192718)

  • 1. Challenges in the multidisciplinary management of stage IV colon and rectal cancer.
    Piso P; Arnold D; Glockzin G
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):317-26. PubMed ID: 25192718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical look at local-regional management of peritoneal metastasis.
    Chan CH; Cusack JC; Ryan DP
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):153-8. PubMed ID: 25475577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.
    Ramírez-Plaza CP; Moreno-Ruiz FJ; Pérez-Daga JA
    World J Surg Oncol; 2015 Aug; 13():233. PubMed ID: 26231227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
    Chua TC; Yan TD; Zhao J; Morris DL
    Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of colorectal liver metastases in patients with peritoneal carcinomatosis.
    Izzo F; Piccirillo M; Palaia R; Albino V; Di Giacomo R; Mastro AA
    J Surg Oncol; 2009 Sep; 100(4):345-7. PubMed ID: 19697443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
    Eveno C; Passot G; Goéré D; Soyer P; Gayat E; Glehen O; Elias D; Pocard M
    Ann Surg Oncol; 2014 Jun; 21(6):1792-800. PubMed ID: 24337648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of synchronous colorectal liver metastases].
    Dupré A; Gagnière J; Chen Y; Rivoire M
    Bull Cancer; 2013 Apr; 100(4):363-71. PubMed ID: 23559319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
    Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
    J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable? What should the radiologist know.
    Dromain C; Caramella C; Dartigues P; Goere D; Ducreux M; Deschamps F
    Diagn Interv Imaging; 2014 May; 95(5):513-23. PubMed ID: 24794253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
    Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
    J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literature.
    Vicente D; Avital I; Stojadinovic A
    World J Surg Oncol; 2015 Jun; 13():2. PubMed ID: 26264074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
    Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D
    J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to increase the resectability of liver metastases from colorectal cancer.
    Fusai G; Davidson BR
    Dig Surg; 2003; 20(6):481-96. PubMed ID: 13679642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Riss S; Mohamed F; Dayal S; Cecil T; Stift A; Bachleitner-Hofmann T; Moran B
    Eur J Surg Oncol; 2013 Sep; 39(9):931-7. PubMed ID: 23810280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of colorectal liver metastases].
    Folprecht G
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2098-103. PubMed ID: 24085366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.